Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 11/10/2011
PIL Exforge 10mg/160mg film coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/10/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 22/08/2011 and displayed until 11/10/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 27/05/2009 and displayed until 22/08/2011
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 01/05/2009 and displayed until 27/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 30/07/2008 and displayed until 01/05/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to information about pregnancy or lactation
Updated on 12/02/2007 and displayed until 30/07/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  valsartan
  amlodipine besilate